Skip to main content
Article thumbnail
Location of Repository

Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke

By Laura J. Gray, Nikola Sprigg, Parveen Rashid, Mark Willmot and Philip M.W. Bath

Abstract

High blood pressure (BP), pulse pressure (PP), and rate pressure product (RPP) areeach associated independently with a poor outcome in acute ischemic stroke.\ud Whereas nitric oxide (NO) donors, such as glyceryl trinitrate (GTN), lower blood pressure in acute ischemic stroke, their effect on other hemodynamic measures is not known. We performed a systematic review of the effects of NO donors on systemic hemodynamic measures in patients with acute/subacute stroke. Randomized controlled trials were identified from searches of the Cochrane Library, Pubmed, and Embase. Information on hemodynamic measures, including systolic BP (SBP), diastolic BP (DBP), and heart rate, were assessed, and hemodynamic derivatives of these were calculated: PP (PP SBP DBP), mean arterial pressure (MAP DBP PP/3), mid blood pressure (MBP (SBP DBP)/2), pulse pressure index (PPI PP/MAP), and RPP (RPP SBP HR). The effect of treatment on hemodynamic measures was calculated as the weighted mean difference (WMD) between treated and control groups with adjustment for baseline.\ud Results: Three trials involving 145 patients were identified; 93 patients received the NO donor, GTN, and 52 control. As compared with placebo, GTN significantly reduced SBP (WMD -9.80 mmHg, p< 0.001), DBP (WMD -4.43 mmHg, p<0.001), MAP (WMD -6.41 mmHg, p< 0.001), MBP (WMD -7.33 mmHg,p<0.001), PP (WMD -6.11 mmHg, p<0.001 ) and PPI (WMD -0.03, p=0.04 ). 3 GTN increased HR (WMD +3.87 bpm, p<0.001) and non-significantly lowered RPP (WMD -323 mmHg.bpm, p=0.14).\ud Conclusion: The NO donor GTN reduces BP, PP and other derivatives in acute and subacute stroke whilst increasing heart rate

Publisher: Elsevier
Year: 2006
OAI identifier: oai:eprints.nottingham.ac.uk:464
Provided by: Nottingham ePrints

Suggested articles

Citations

  1. (2002). and for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke
  2. (2002). Collaboration. Age specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet
  3. Relationship between functional outcome and baseline blood pressure, pulse pressure and heart rate in acute ischaemic stroke: data from the TAIST trial. Cerebrovasc.Dis. 2005; 19(suppl 2): 36 (abstract).
  4. (2001). Twenty-four hour systolic blood pressure predicts long-term mortality following acute stroke.
  5. (2004). Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry.
  6. Scandinavian Candesartan Acute Stroke Trial
  7. (2001). Major ongoing stroke trials. Efficacy of Nitric Oxide
  8. (2005). The CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design.
  9. (2003). The potential of nitric oxide therapeutics in stroke.
  10. (2005). A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide
  11. (2001). The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis
  12. (2003). The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke.
  13. (2006). Transdermal Glyceryl Trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension
  14. Nitric oxide donors (nitrates), Larginine, or nitric oxide synthase inhibitors in acute ischaemic stroke (Cochrane Review),
  15. (1995). Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials
  16. (2002). Review Manager (RevMan) version 4.2, The Cochrane Collaboration.
  17. Statistical Software: Release 7.0. 2001: College Station, TX:
  18. (1998). Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis
  19. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial -INTERACT,
  20. (2001). Blood pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke (Cochrane Review). Cochrane Database Syst Rev
  21. (1988). Low dose beta blockade in acute stroke (&quot;BEST&quot; trial): an evaluation. BMJ doi
  22. (2000). Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke doi
  23. (2003). of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. doi
  24. (2005). Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the doi
  25. (1997). The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovascular Diseases doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.